PATIENTS WITH CLI THE THREE YEARS OUTCOME OF ENDOLUMINAL BYPASS FOR PATIENTS WITH CLI

Similar documents
Comparing endoluminal bypass to open fem-pop bypasses; Final 1-year results of the SUPERB trial

RESULTS OF VIABAHN IN AORTO ILIAC OCCLUSION

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)

IVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC

2-YEAR DATA SUPERA POPLITEAL REAL WORLD

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions

Endovascular treatment of severe TASC C and D external iliac artery occlusive disease. SAINT-LEBES Bertrand Toulouse FRANCE

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

Robert W. Fincher, DO The Ritz-Carlton, Dove Mountain Marana, Arizona February 7th, 2015

Balloon Expandable Covered Stents. Suddenly a Crowded Space

Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 24-Month Results

Disclosures. In the DCB Era, How Do I Choose To Use a Stent? When to Stent and What Devices to Use in the SFA

Mid-term outcome of CERAB for aorto-iliac occlusive disease. Michel Reijnen Rijnstate Arnhem The Netherlands

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Preliminary report

Disclosures. Iliac Stenting: How could I mess this up? Surgery vs. Stenting: Gold Standard?

Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA

I am no good at debates!

The Crack and Pave technique for highly resistant calcified lesions. Manuela Matschuck MD University Hospital Leipzig Department Angiology

Accurate Vessel Sizing Drives Clinical Results. IVUS In the Periphery

Hybrid Heparin-Bonded Nitinol and eptfe Stent in the treatment of popliteal artery occlusion: mid- term follow-up results.

Pedal Bypass With Deep Venous Arterialization:

The LIMBO trial: a RCT investigating adventitial dexamethasone infusion to prevent restenosis in BTK arteries utilizing a novel angiographic endpoint

The latest evidences from the DES trials in peripheral arterial disease

Intervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI

Update from Korea on the Lutonix SFA registry 12 month data

How do I use mechanical debulking for the treatment of arterial occlusions

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step -

Chimney technique combined with aortoiliac stenting for the treatment. disease. of juxtarenal aortoiliac occlusive

Anatomical challenges in EVAR

Wifi classification does not predict limb amputation risk in dialysis patients following critical limb ischemia revascularization

Study of a Balloon-Expandable Covered Stent for Obstructive Lesions in the Iliac Artery

Surgical Bypass or. Zilver PTX. 12 months preliminary data. LINC 2016, Leipzig. Marc Bosiers, MD. Marc Bosiers Koen Deloose Joren Callaert

CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION

DIFFICULT ACCESS REMAINS A CONTRAINDICATION FOR EVAR APOSTOLOS K. TASSIOPOULOS, MD, FACS PROFESSOR AND CHIEF DIVISION OF VASCULAR SURGERY

Extreme SFA Lesions: DETOUR I 12- Month Results in Lesions >30cm. Sean Lyden, MD Chairman Vascular Surgery Cleveland Clinic Cleveland, Ohio

Treatment Strategies for Long Lesions of greater than 20 cm

Robert F. Cuff, MD FACS SHMG Vascular Surgery

The Fate of Unexpected Events Occurring in Standard EVAR

Stents for The Common Femoral Artery: The Good, The Bad and The Ugly

Imaging Strategy For Claudication

Micromesh technology in carotid artery treatment what is next? Max Amor MD Clinique Louis Pasteur, Essey-Les-Nancy France

GORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability. Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands

Disclosures: Stent-grafts for Long-Segment SFA Disease: Better than the Alternatives? SFA Treatment Overview: Longer Lesions 4/18/2013

Variation of stent placement for distal abdominal aorta Lesion

Catheter-Directed Thrombolysis for Acute Limb Ischemia. Hwan Jun Jae MD Seoul National University Hospital Seoul, Korea

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE

Novel distal popliteal artery puncture technique in supine position for chronic femoropopliteal arterial occlusion; frontal popliteal puncture

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial)

Hypogastric Preservation Using Retrograde Endovascular Bypass

Long-term Zilver PTX Data from Japan: 5-year Results in the Real World

ISR-treatment The Leipzig experience with purely mechanical debulking. Sven Bräunlich Department for Angiology University-Hospital Leipzig, Germany

Present & future of below the knee stenting

Early Clinical Results with the Valiant Mona LSA Branch Stent-Graft

Expanding to every demand: The GORE VIABAHN VBX Stent Graft

Christian Wissgott MD, PhD Assistant Director, Radiology Westküstenkliniken Heide

ILLUMENATE FIH Direct DCB Cohort 12-Month Results

Angiographic dissection pattern and patency outcomes of post balloon angioplasty for SFA lesions -a retrospective multi center analysis-

CLI Treatment Using Long and Scoring Balloons

Long Lesions: Primary stenting or DCB first? John Laird MD Adventist Heart and Vascular Institute, St. Helena, CA

SFA In-stent Restenosis

PRISM Trial. Retrospective Case Review of Technical Success Using the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery

The BATTLE Trial Comparing Bare Metal to Drug Eluting Stents for Intermediate Length Lesions of the SFA

Endovascular Should Be Considered First Line Therapy

Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort

Disclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention

Low profile TEVAR: is it an added value? Michel Bosiers, G. Torsello Münster

Outcomes Of DCB Use In Real World Registries: 2 Year Results From The INPACT Global Registry

The essentials for BTK procedures: wires, balloons, what else

Distal hybrids - an option in long SFA CTO accompanied by severely compromized crural runoff

Introduction History Preceded by Arterial Doppler and ABI Indications

CUSTOM-MADE SCALLOPED THORACIC ENDOGRAFTS IN DIFFERENT HOSTILE AORTIC ANATOMIES

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial)

Critical limb ischemia due to an occlusion of an aorto-biiliac prothesis step by step case presentation and decision making

Aggressive BTK Revascularization and Advanced Wound Care - Patient Specific Therapy Concepts

Merits and demerits of DES, DEB or covered stent in lower extremity arterial occlusive disease 성균관의과대학삼성서울병원순환기내과최승혁

How effective is preservation when viewed through a clinical and economic lens?

Popliteal Artery Aneurysms: Diagnosis and Repair Options

Surgical Options for revascularisation P E T E R S U B R A M A N I A M

Challenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak

Massimiliano Fusaro, MD on behalf of ISAR-STATH Investigators. Deutsches Herzzentrum München, Technische Universität München Munich - Germany

Cutting/scoring balloon Cryoplasty Drug-eluting balloon Brachytherapy Debulking Restent (BMS or DES) John R. Laird, MD

Mechanical thrombectomy in peripheral interventions: A multitask and effective tool in a widening scenario. Current evidence and technical tips.

Clinical benefits on DES Patient s perspectives

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?

Talent Abdominal Stent Graft

COMBINED TECHNIQUE CHIMNEY + FENESTRATED ENDOGRAFT FOR COMPLEX ANEURYSMS ERIC DUCASSE - MD PHD FEVBS CHU BORDEAUX

Diagnosis and Management of Femoral Access Site Complications IV: Novel Techniques for Endovascular Rescue

FLEXIBLE, BALOON EXPANDABLE

The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan

Comparison of Angiographic Dissection Patterns Caused by Long vs Short Balloons During Balloon Angioplasty for Chronic Femoropopliteal Occlusions

DCB in my practice: How the evidence influences my strategy. Yang-Jin Park

Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer?

Durable outcomes. Proven performance.

Pulsar stent technology

Evidence-Based Optimal Treatment for SFA Disease

Management of In-stent Restenosis after Lower Extremity Endovascular Procedures

Atherectomy is Still Live and Effective. John R. Laird, MD Professor of Medicine Medical Director of the Vascular Center UC Davis Health System

Transcription:

JORGE FERNÁNDEZ NOYA ANGIOLOGY AND VASCULAR SURGERY DEPARTMENT UNIVERSITARY CLINICAL HOSPITAL SANTIAGO DE COMPOSTELA THE THREE YEARS OUTCOME OF ENDOLUMINAL BYPASS FOR

Disclosure Speaker name: Jorge Fernández Noya I have the following potential conflicts of interest to report: X Consulting: GORE Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s) I do not have any potential conflict of interest

Nitinol Stent Inner layer of eptfe Superb flexibility Low fractures reported in the SFA Heparin-bonded luminal surface for thrombo-resistance Actually up to 25 cm lenght

VIABAHN Increased trombogenicity?? Without marks in the edges. The delivery system is not precise Without enought radial force Increased number of Acute ischemia (Occlusion of collaterals)

LITERATURE WORLD EXPERIENCE OUR EXPERIENCE

ENDOLUMINAL BY-PASS Planning with Duplex-Scan or CT. Usually ipsilateral approach. Angiogram: Looking for healthy vessel proximal and distal ( 1cm) Don t cover genicular arteries Post-dilatation inside the device. Avoid Oversizing ( <20%) Follow-up is critical

ENDOLUMINAL BY-PASS Planning with Duplex-Scan or CT.

ENDOLUMINAL BY-PASS Avoid Oversizing ( <20%) Effects of Device Sizing: Proximal 91% p<0.05 70% Effects of Device Sizing: Distal 87% 72% p=0.09 VIPER TRIAL

ENDOLUMINAL BY-PASS Angiogram: Looking for proximal and distal ( 1cm) healthy vessel

ENDOLUMINAL BY-PASS Don t cover genicular arteries

ENDOLUMINAL BY-PASS Post-dilatation inside the device.

OUR EXPERIENCE RetrospectIive June 2010-june 2013. 94 Patients ( 101 Limbs ) Average Follow up 383 days. 73.5 % male Average age: 72.5 years old.

OUR EXPERIENCE 0,7 0,6 0,5 0,4 0,3 0,2 0,1 0

OUR EXPERIENCE DISTAL PTA/STENT DISTAL SURGERY PROXIMAL BARE STENT PROXIMAL FEM- OPEN SURGERY NO ASSOCIATE PROCEDURE. ILIAC OPEN SURGERY ILIAC PTA/STENT 57.1% ASSOCIATE PROCEDURE

OUR EXPERIENCE CATEGORY 4: ISCHEMIC REST PAIN 28.5% CATEGORY 5: MINOR TISSUE LOSS 63.3% CATEGORY 6: MAJOR TISSUE LOSS 8.2%

OUR EXPERIENCE LESIONS CHARACTERISTICS Occlusions 78.6% Stenosis 21.4% Calcification Mild 41.8% Moderate 37.8% Severe 20.4% 58.2% Length < 10 cm 15.3% 10-20 cm 32.7% >20 cm 52% Run off 0 5.1% 1 52% 84.7% 57.1% 2 31.6% 3 11.2%

OUR EXPERIENCE GLOBAL RESULTS Primary Patency Secondary Patency Limb Salvage Time ( Days) Time ( Days) Time ( Days) PRIMARY PATENCY SECONDARY PATENCY LIMB SALVAGE 1 YEAR 78.8 % 82.2% 88% 2 YEARS 71,7 % 74,8 % 82,1%

OUR EXPERIENCE DIABETES Primary Patency DIABETICS----- NON-DIABETICS---- Limb Salvage Time ( Days) PRIMARY PATENCY DIABETICS NON- DIABETICS 1 year 78.3% 79.5% 2 years 70.7% 74.2% Time ( Days) LIMB SALVAGE DIABETICS NON DIABETICS 1 year 89.8% 84.2% 2 years 80.4% 84.2%

OUR EXPERIENCE RUTHERFORD CATEGORY --- Rutherford 4 Primary Patency --- Rutherford 5 --- Rutherford 6 Limb Salvage Time ( Days) PRIMARY PATENCY 4 5 6 1 year 75.3% 83.2% 50% 2 years 75.3% 71.3% ----- Time ( Days) LIMB SALVAGE 4 5 6 1 year 94.7% 91.6% 37.5% 2 years 94.7% 85% -----

OUR EXPERIENCE LENGTH < 10 cm--- 10-20 cm---- PRIMARY PATENCY <10 cm 10-20 cm >20 cm 1 year 86.2% 89.4% 69.6% Primary Patency >20 cm 2 years 76.6% 89.4% 58% Time ( Days) LENGTH>20 Cm Primary patency 1 STENT 79% 2 STENT 64.7% 3 STENT 66.7%

OUR EXPERIENCE LENGTH < 10 cm--- Limb Salvage 10-20 cm---- >20 cm LIMB SALVAGE <10 cm 10-20 cm >20 cm 1 year 86.7% 93.3% 85.4% Time ( Days) 2 years 69.3% 88.1% 85.4%

CONCLUSIONS Long SFA lesions and CLI are challenging cases Endoluminal by-pass technique offers good results 250 mm graft to avoid the overlapping (ENDO-BY-PASS) Correct sizing is key / Avoid Oversizing Surveillance is critical The edge-focal stenosis is easier to treat

THE THREE YEARS OUTCOME OF ENDOLUMINAL BYPASS FOR